Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Lambert

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
The Journal of General Virology|June 1, 1987
Immediate persistent infection by human parainfluenza virus 3: unique fusion properties of the persistently infected cellsS L Wechsler, D M Lambert, M S Galinski, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 10, 2014
Ancient population genomics and the study of evolutionM Parks, S Subramanian, C Baroni, et al.
Pharmaceutical Research|January 1, 1996
Targeting of drug to the hepatocytes by fatty acids. Influence of the carrier (albumin or galactosylated albumin) on the fate of the fatty acids and their analogsV Charbon, I Latour, D M Lambert, et al.
AIDS Research and Human Retroviruses|June 10, 1996
Potent inhibition of HIV type 1 infection of mononuclear phagocytes by synthetic peptide analogs of HIV type 1 protease substratesC S Dukes, T J Matthews, D M Lambert, et al.
Molecular Genetics and Metabolism|July 20, 2001
In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 geneD M Lambert, O A Mamer, B R Akerman, et al.
American Journal of Medical Genetics|July 23, 1998
Keutel syndrome: further characterization and reviewA S Teebi, D M Lambert, G M Kaye, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1993
1,3-Diacylaminopropan-2-ols and corresponding 2-acyl derivatives as drug carriers: unexpected pharmacological propertiesD M Lambert, L Neuvens, F Mergen, et al.
Molecular Genetics and Metabolism|September 10, 1999
Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohortB R Akerman, H Lemass, L M Chow, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120T K Hart, R Kirsh, H Ellens, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1993
Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue cultureP L Black, M B Downs, M G Lewis, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
The Journal of General Virology|June 1, 1987
Immediate persistent infection by human parainfluenza virus 3: unique fusion properties of the persistently infected cellsS L Wechsler, D M Lambert, M S Galinski, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 10, 2014
Ancient population genomics and the study of evolutionM Parks, S Subramanian, C Baroni, et al.
Pharmaceutical Research|January 1, 1996
Targeting of drug to the hepatocytes by fatty acids. Influence of the carrier (albumin or galactosylated albumin) on the fate of the fatty acids and their analogsV Charbon, I Latour, D M Lambert, et al.
AIDS Research and Human Retroviruses|June 10, 1996
Potent inhibition of HIV type 1 infection of mononuclear phagocytes by synthetic peptide analogs of HIV type 1 protease substratesC S Dukes, T J Matthews, D M Lambert, et al.
Molecular Genetics and Metabolism|July 20, 2001
In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 geneD M Lambert, O A Mamer, B R Akerman, et al.
American Journal of Medical Genetics|July 23, 1998
Keutel syndrome: further characterization and reviewA S Teebi, D M Lambert, G M Kaye, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1993
1,3-Diacylaminopropan-2-ols and corresponding 2-acyl derivatives as drug carriers: unexpected pharmacological propertiesD M Lambert, L Neuvens, F Mergen, et al.
Molecular Genetics and Metabolism|September 10, 1999
Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohortB R Akerman, H Lemass, L M Chow, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120T K Hart, R Kirsh, H Ellens, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1993
Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue cultureP L Black, M B Downs, M G Lewis, et al.
Pageof 10